Clinical trial
Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin.
NCT01845246 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin.
- Lead sponsor
- Parc de Salut Mar
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- August 31, 2015
- Enrollment
- 101 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
multidrug resistant gram negative bacterial infections